Apoya, Renato S.
HRN: 25-70-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/13/2024
08/20/2024
IV
2.25g
Q6h
Diabetic Foot Right
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes